Sort
17,288 grants matching “multiple sclerosis”
Computationally informed discovery of scavenging-sparing inhibitors of CC chemokine receptor 2
$197,448Irina Kufareva · University Of California, San Diego · R21 · FY2021 · AI
Coupled level set framework for retinal segmentation and atlasing in SD-OCT
$197,444Jerry L Prince · Johns Hopkins University · R21 · FY2012 · EY
Genetically Engineered Antigen Specific Treg to Treat Autoimmunity
$197,396Jeffrey A Bluestone · University Of California, San Francisco · U19 · FY2009 · AI
Clinical subjects and recruitment
$197,364Albert C Shaw · Yale University · U19 · FY2024 · AI
Human CD8+ T Cell Tolerance by Nondepleting Humanized CD8-Specific Antibody
$197,272Roland Michael Tisch · Univ Of North Carolina Chapel Hill · R21 · FY2016 · AI
IMAGING TRYPTOPHAN METABOLISM IN TUBEROUS SCLEROSIS
$197,249Wayne State University · R01 · FY2002 · NS
Genetically Engineered Antigen Specific Treg to Treat Autoimmunity
$197,234Jeffrey A Bluestone · University Of California, San Francisco · U19 · FY2011 · AI
Proteomic and Functional Analyses of Astrocyte Exosomes
$197,170Stephen J Crocker · University Of Connecticut Sch Of Med/Dnt · R21 · FY2016 · NS
The Role of Complement in Cerebrospinal Fluid Shunt Infections
$197,132Gwenn L Skar · University Of Nebraska Medical Center · K08 · FY2024 · NS
Clinical Translation of a Neuron Protective Recombinant Human Antibody
$197,125Moses Rodriguez · Mayo Clinic Rochester · R21 · FY2012 · NS
Synthetic Lethal Combination of KRP203/Fingolimod with PI3K signaling for glioblastoma multiforme death by catastrophic vacuolization
$197,104Atsuo Sasaki · University Of Cincinnati · R21 · FY2017 · NS
Repurposing a Generic ACE Inhibitor to Treat Multiple Sclerosis
$196,923Tomasz Sablinski · Transparency Life Sciences, Llc · R44 · FY2014 · TR
TPA MEDIATED NEURODEGENERATION AND MICROGLIA ACTIVATION
$196,917State University New York Stony Brook · R01 · FY2000 · NS
Therapy for long-COVID in a preclinical model
$196,875Daniel Kaufman · University Of California Los Angeles · R21 · FY2025 · AI
Immunologic Characterization of CSF microglia in multiple sclerosis
$196,875Gregory Wu · Washington University · R21 · FY2022 · NS
Segmentation and volumetric quantification of thalamic nuclei for assessing MS
$196,835Jerry L Prince · Johns Hopkins University · R21 · FY2013 · NS
MULTIPLE SCLEROSIS RESEARCH PROGRAM
$196,760The Governors Of The University Of Alberta · · FY2021 · Defense Health Agency
Genetic Approaches to the Study of Plasmacytoid Dendritic Cell Function
$196,694Boris Reizis · Columbia University Health Sciences · R21 · FY2010 · AI
Nanotherapeutics for acute kidney injury
$196,667Mark Douglas Okusa · University Of Virginia · R21 · FY2012 · DK
Genetically Engineered Antigen Specific Treg to Treat Autoimmunity
$196,503Jeffrey A Bluestone · University Of California, San Francisco · U19 · FY2012 · AI
Vitamin D and the Immune System
$196,491Sylvia S Christakos · Univ Of Med/Dent Of Nj-Nj Medical School · R21 · FY2012 · AI
The Role of Il-13 in Regulating Th17 Cytokine Production
$196,422Ray Stokes Peebles · Vanderbilt University · R21 · FY2012 · HL
Neuroinflammation in Generation of NMDAR Autoantibodies
$196,319Xianjin Zhou · University Of California, San Diego · R21 · FY2019 · MH
Inosine in the over-the-counter treatment of MS
$196,250Thomas Jefferson University · R21 · FY2004 · AT
Investigation and Treatment of Ocular Motor Disorders
$196,250Richard John Leigh · Case Western Reserve University · R01 · FY2010 · EY